Vimarsana
Biggest News Aggregation in the World

Page 32 - Maturity Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maturity Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maturity Date Today - Breaking & Trending Today

DIGL WORL : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K -April 01, 2024 at 06:12 am EDT - Vimarsana News

DIGL WORL : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K -April 01, 2024 at 06:12 am EDT

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Digital World Acquisition Corp. ...

I 80 Gold : Convertible Debenture Indenture dated February 22, 2023 - Form 6-K -April 01, 2024 at 12:55 pm EDT - Vimarsana News

I 80 Gold : Convertible Debenture Indenture dated February 22, 2023 - Form 6-K -April 01, 2024 at 12:55 pm EDT

I-80 GOLD CORP. and TSX TRUST COMPANY CONVERTIBLE DEBENTURE INDENTURE ...

Centrais Eletricas Brasileiras S A : CERTIFICATE MINUTES OF THE ONE THOUSAND AND EIGHTH MEETING OF THE BOARD OF DIRECTORS OF CENTRAIS ELÉTRICAS BRASILEIRAS S.A. – ELETROBRAS - Form 6-K -March 29, 2024 at 06:19 am EDT - Vimarsana News

Centrais Eletricas Brasileiras S A : CERTIFICATE MINUTES OF THE ONE THOUSAND AND EIGHTH MEETING OF THE BOARD OF DIRECTORS OF CENTRAIS ELÉTRICAS BRASILEIRAS S.A. – ELETROBRAS - Form 6-K -March 29, 2024 at 06:19 am EDT

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or...

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

--Resubmission of NDA On Track for Early Q2 24— --Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today r

Source: yahoo.com
Vast Renewables Limited Announces Operational and Financial Results for First Half of Fiscal 2024 - Vimarsana News

Vast Renewables Limited Announces Operational and Financial Results for First Half of Fiscal 2024

Operational and Funding Highlights Investment of €10.0 million from EDF Australia, a subsidiary of EDF GroupEquity investment from the Canberra Airport Group valued at USD $9.2 millionSubsequently...